Similar articles

• [Combination therapy with etoposide, adriamycin and cisplatin in advanced primary and recurrent gastric cancer].

  Tokunaga A, Onda M, Mizutani T, Miyamoto M, Nomura T, Hayashi H, Kiyama T, Umehara M, Nishi K, Andoh T, et al. Tokunaga A, et al. Gan To Kagaku Ryoho. 1989 Dec;16(12):3713-8. Gan To Kagaku Ryoho. 1989. PMID: 2596854 Japanese.
• [Combination chemotherapy with etoposide, ADM, and CDDP (EAP) for advanced gastric cancer].

  Taguchi T, Ohta J, Orino M, Ohshiba S, Yamada S, Okazima K, Ohtani T, Hurukawa H, Iwanaga T, Numata N, et al. Taguchi T, et al. Gan To Kagaku Ryoho. 1990 Nov;17(11):2191-6. Gan To Kagaku Ryoho. 1990. PMID: 2241183 Clinical Trial. Japanese.
• [Evaluation of the combination of chemotherapy with etoposide, adriamycin and cisplatin (EAP) in advanced or recurrent gastric cancer].

  Terata N, Sano H, Ishibashi H, Tani T, Hanasawa K, Endo Y, Kurumi Y, Shibata J, Kodama M, Tsuji K, et al. Terata N, et al. Gan To Kagaku Ryoho. 1993 Apr;20(5):611-6. Gan To Kagaku Ryoho. 1993. PMID: 8470918 Japanese.
• [Treatment of recurrent gastric cancer].

  Tsushima K, Sakata Y. Tsushima K, et al. Gan To Kagaku Ryoho. 1998 Feb;25(3):321-6. Gan To Kagaku Ryoho. 1998. PMID: 9492823 Review. Japanese.
• Platinum based chemotherapy to treat recurrent Sertoli-Leydig cell ovarian carcinoma during pregnancy.

  Tomlinson MW, Treadwell MC, Deppe G. Tomlinson MW, et al. Eur J Gynaecol Oncol. 1997;18(1):44-6. Eur J Gynaecol Oncol. 1997. PMID: 9061323 Review. No abstract available.